HUTCHMED (CHINA) LIMITED ORD USD0.1 revenue for the last year amounted to 658.29 M GBP, the most of which — 286.96 M GBP — came from its highest performing source at the moment, Oncology/Immunology - Research and Development, the year earlier bringing 32.49 M GBP. The greatest contribution to the revenue figure was made by China — last year it brought HUTCHMED (CHINA) LIMITED ORD USD0.1 381.80 M GBP, and the year before that — 353.42 M GBP.